Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction
Top Cited Papers
Open Access
- 9 December 2004
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (24) , 2481-2488
- https://doi.org/10.1056/nejmoa041489
Abstract
Implantable cardioverter–defibrillator (ICD) therapy has been shown to improve survival in patients with various heart conditions who are at high risk for ventricular arrhythmias. Whether benefit occurs in patients early after myocardial infarction is unknown.Keywords
This publication has 18 references indexed in Scilit:
- Changing Late Prognosis of Acute Myocardial InfarctionCirculation, 2003
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening ArrhythmiasCirculation, 2001
- The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): Study protocolAmerican Heart Journal, 2000
- Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarctionPublished by Elsevier ,1998
- Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular ArrhythmiaNew England Journal of Medicine, 1996
- Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarctionJournal of the American College of Cardiology, 1996
- Decreased heart rate variability and its association with increased mortality after acute myocardial infarctionThe American Journal of Cardiology, 1987
- The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.Circulation, 1984
- Clinical classification of cardiac deaths.Circulation, 1982